Levamisole and HBsAg Positive Chronic Persistent Hepatitis.

Archives of Disease in Childhood - United Kingdom
doi 10.1136/adc.53.9.764
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Correlation of Hepatitis B Virus Viral Load and HBeAg Status in HBsAg Positive Patients

Asian Journal of Pharmacy and Pharmacology
2019English

Hepatitis B Virus DNA and E Antigen in Serum From Blood Donors Positive for HBsAg

BMJ
1985English

HBsAg Loss in Chronic Hepatitis B: Pointers to the Benefits of Curative Therapy

Hepatology International
Hepatology
2016English

Performance Evaluation of HBsAg by Lumipulse HBsAg-HQ: The Agreement With HBsAg by Architect HBsAg-QT and the Effectiveness in Predicting Liver Tissue Pathological States of Chronic Hepatitis B Patients

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

P214: Hepatitis E Virus Super-Infection and Progression of Liver Disease in Vietnamese HBsAg-positive Patients

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2015English

Delta Agent Infection in Acute Hepatitis and Chronic HBsAg Carriers With and Without Liver Disease.

Gut
Gastroenterology
1984English

The Clinical Significance of Quantitative HBSAG in Patients With HBEAG Negative Chronic Hepatitis B

Acta Medica Saliniana
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy